Arkolith/Insider Trading/STTK/Form 4

OrbiMed Capital GP IX LLC

DirectorShattuck Labs, Inc. (STTK) · full profile →Form 4 · filed Sep 2, 2025
Net Buying
Open-Market Buys
$5.5M
Open-Market Sells
$0
Net Open-Market Flow
$5.5M
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2025Buy(P)5.3M$0.87$4.6M5.3M
Aug 25, 2025Buy(P)1.1M$0.87$914K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2025Buy(P)2.0M——2.0M
Aug 25, 2025Buy(P)10.1M——10.1M
Aug 25, 2025Buy(P)3.1M——3.1M
Aug 25, 2025Buy(P)15.4M——15.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000840) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML